MyoKardia Announces Closing of Initial Public Offering

SOUTH SAN FRANCISCO, Calif., Nov. 3, 2015 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK) today announced the closing of its initial public offering of 6,253,125 shares of common stock at a public offering price of $10.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 815,625 shares of common stock. All of the shares sold in the offering were offered by MyoKardia. The shares began trading on The NASDAQ Global Select Market under the ticker symbol "MYOK" on October 29, 2015. The Company estimates net proceeds from the offering to be approximately $55.7 million, after deducting underwriting discounts and commissions and estimated offering expenses.

Credit Suisse Securities (USA) LLC and Cowen and Company, LLC acted as lead book-running managers. Wells Fargo Securities acted as book-running manager. Wedbush PacGrow acted as co-manager.

A registration statement relating to the securities being sold in the offering was declared effective by the Securities and Exchange Commission on October 28, 2015. This offering is being made only by means of a prospectus. Copies of the final prospectus relating to this offering may be obtained by contacting: Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, One Madison Avenue, New York, NY 10010, by telephone at (800) 221-1037, or by email at [email protected]; or Cowen and Company, LLC, c/o Broadridge Financial Services, Attention: Prospectus Department, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (631) 274-2806 or by fax at (631) 254-7140.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

CONTACT: Media Contacts:

         Katie Engleman
         Pure Communications, Inc.
         910-509-3977
         [email protected]

         Investor Contacts:

         Matt Clawson
         Pure Communications, Inc.
         949-370-8500
         [email protected]

You May Also Be Interested In

• General Atlantic weighs return to IPO plans after 2023 filing, WSJ reports
• Xos wins U.S. Air Force contract for mobile charging system
• Prosecutors said to examine four firms in Mark Walter fraud probe